Page last updated: 2024-10-29

iomeprol and Acute Generalised Exanthematous Pustulosis

iomeprol has been researched along with Acute Generalised Exanthematous Pustulosis in 2 studies

iomeprol: structure given in first source
iomeprol : A benzenedicarboxamide compound having N-substituted carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and a glycoloyl(methyl)amino group at the 5-position.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Navarro Triviño, FJ1
Linares-González, L1
Ródenas-Herranz, T1
Llamas-Molina, JM1
Ruiz-Villaverde, R1
Machet, P1
Marcé, D1
Ziyani, Y1
Dumont, M1
Cornillier, H1
Jonville-Bera, AP1
Machet, L1

Other Studies

2 other studies available for iomeprol and Acute Generalised Exanthematous Pustulosis

ArticleYear
Acute localized exanthematous pustulosis (ALEP) induced by iomeprol (Iomeron 350): A diagnostic challenge.
    Contact dermatitis, 2021, Volume: 85, Issue:1

    Topics: Acute Generalized Exanthematous Pustulosis; Contrast Media; Dermatitis, Allergic Contact; Female; Hu

2021
Acute generalized exanthematous pustulosis induced by iomeprol with cross-reactivity to other iodinated contrast agents and mild reactions after rechallenge with iopromide and oral corticosteroid premedication.
    Contact dermatitis, 2019, Volume: 81, Issue:1

    Topics: Acute Generalized Exanthematous Pustulosis; Adrenal Cortex Hormones; Aged, 80 and over; Contrast Med

2019